Literature DB >> 31186125

Cancer Immunotherapies.

Philip J Bergman1.   

Abstract

The enhanced understanding of immunology experienced over the last 4 decades afforded through the tools of molecular biology has recently translated into cancer immunotherapy becoming one of the most exciting and rapidly expanding fields. Human cancer immunotherapy is now recognized as one of the pillars of treatment alongside surgery, radiation, and chemotherapy. The field of veterinary cancer immunotherapy has also rapidly advanced in the last decade with a handful of commercially available products and a plethora of investigational cancer immunotherapies that will hopefully expand the veterinary oncology treatment toolkit over time.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer vaccine; Canine; Feline; Immunotherapy; Monoclonal antibody

Mesh:

Substances:

Year:  2019        PMID: 31186125     DOI: 10.1016/j.cvsm.2019.04.010

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  12 in total

Review 1.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

Review 2.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

4.  Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells.

Authors:  Fang Huang; Jinjin Zhao; Yiting Wei; Zhifa Wen; Yue Zhang; Xuru Wang; Yanfei Shen; Li-Xin Wang; Ning Pan
Journal:  Int J Nanomedicine       Date:  2020-02-13

5.  Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.

Authors:  Ran Xie; Suwei Dong; Jie Jiang; Conghui Yang; Lanjiang Li; Sheng Zhao; Yunlei Li; Chun Wang; Shujuan Li; Yanbin Xiao; Long Chen
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-12-15

Review 6.  Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System.

Authors:  Tobias Achu Muluh; Zhuo Chen; Yi Li; Kang Xiong; Jing Jin; ShaoZhi Fu; JingBo Wu
Journal:  Int J Nanomedicine       Date:  2021-03-25

7.  T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma.

Authors:  Ellen E Sparger; Hong Chang; Ning Chin; Robert B Rebhun; Sita S Withers; Hung Kieu; Robert J Canter; Arta M Monjazeb; Michael S Kent
Journal:  Front Vet Sci       Date:  2021-12-02

8.  Current Issues in Molecular Biology Journal Enters a New Era.

Authors:  Rafael Franco
Journal:  Curr Issues Mol Biol       Date:  2021-06-18       Impact factor: 2.976

9.  Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.

Authors:  Alessandra Rinah Nogueira Voges; Rodrigo Ubukata; Karina Velloso Braga Yazbek; Otávia Luisa Caballero; Andres Mario Salazar; Cristina de Oliveira Massoco; Maria Lucia Zaidan Dagli
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

10.  Determinants of the Cancer Drug Funding Process in Canada.

Authors:  Joanna Gotfrit; Ashley Jackson; John J W Shin; David J Stewart; Ranjeeta Mallick; Paul Wheatley-Price
Journal:  Curr Oncol       Date:  2022-03-15       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.